<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7091927/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Antiviral compounds isolated in IMC</p>
 </caption>
 <thead>
  <tr>
   <th align="left" colspan="1" rowspan="1" id="0-0-.">
    <i>Compound</i>
   </th>
   <th align="left" colspan="1" rowspan="1" id="0-1-.">
    <i>Viral infections</i>
   </th>
   <th align="center" colspan="1" rowspan="1" id="0-2-.">
    <i>Reference</i>
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>Formycins</td>
   <td>Influenza virus, poliovirus, vaccinia virus, VSV</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR3">3</a>, 
     <a ref-type="bibr" rid="CR4">4</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Coformycin</td>
   <td>HIV</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR5">5</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Oxanosine</td>
   <td>HIV</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR6">6</a>, 
     <a ref-type="bibr" rid="CR7">7</a>, 
     <a ref-type="bibr" rid="CR8">8</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Benanomicins</td>
   <td>HIV</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR9">9</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Kijimicin</td>
   <td>HIV</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR10">10</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Bellenamine</td>
   <td>HIV</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR11">11</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>14- 
    <i>O</i>-acyladriamycins 
   </td>
   <td>(HIV) 
    <sup>a</sup>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR12">12</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Aminoacridines</td>
   <td>(HIV) 
    <sup>a</sup>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR13">13</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Phleomycin</td>
   <td>Poliovirus</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR14">14</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Fusaric acid</td>
   <td>HSV, HBV, HCV, varicella-zoster virus, sindbis virus</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR15">15</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Aclacinomycin A</td>
   <td>Phage 
    <i>ϕ</i>X174 and 
    <i>λ</i>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR16">16</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Clazamycin B</td>
   <td>HSV</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR17">17</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Sarkomycin</td>
   <td>Phage f2</td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR18">18</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Leupeptin</td>
   <td>(Marburg virus) 
    <sup>b</sup>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR21">21</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Antipain</td>
   <td>(Poliovirus) 
    <sup>c</sup>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR24">24</a>, 
     <a ref-type="bibr" rid="CR25">25</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Elastatinal</td>
   <td>(Poliovirus) 
    <sup>c</sup>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR24">24</a>, 
     <a ref-type="bibr" rid="CR25">25</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Pepstatin</td>
   <td>(HIV) 
    <sup>d</sup>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR27">27</a>, 
     <a ref-type="bibr" rid="CR28">28</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td>Siastatin B</td>
   <td>(Influenza virus) 
    <sup>e</sup>
   </td>
   <td>
    <sup>
     <a ref-type="bibr" rid="CR30">30</a>
    </sup>
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p>Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HSV, herpes simplex virus; IMC, Institute of Microbial Chemistry; VSV, vesicular stomatitis virus.</p>
  <p>
   <sup>a</sup>Inhibition of HIV reverse transcriptase. 
  </p>
  <p>
   <sup>b</sup>Inhibition of unknown host proteases involved in virus entry. 
  </p>
  <p>
   <sup>c</sup>Inhibition of poliovirus 2A protease. 
  </p>
  <p>
   <sup>d</sup>Contributed to the development of anti-HIV drugs against HIV protease. 
  </p>
  <p>
   <sup>e</sup>Inhibition of sialidase activity of influenza virus by epimeric analog of siastatin B. 
  </p>
 </tfoot>
</table>
